Zepbound and related products could generate more than $50 billion of sales in 2029. There is a lot more in Lilly’s pipeline.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.